DBA Italia - Glycoselect

GlycoSeLect enters strategic agreement with DBA Italia

Dublin-Milan, September 2021

GlycoSeLect is pleased to announce that we have entered into a strategic agreement with DBA Italia, Milan, Italy. Effective from October 1st, 2021, DBA Italia s.r.l. is appointed as GlycoSeLect’s distributor for Italy for our innovative recombinant lectin products, devoted to the life science industries.

We are confident that our partnership with DBA Italia s.r.l. will provide our customers in Italy with outstanding quality and exceptional customer service, achieving strong supply chains by consistently providing them with our innovative glycan-specific protein products and quick deliveries.

For more information, contact GlycoSeLect here or DBA Italia here.

About GlycoSelect Ltd

GlycoSeLect Ltd develops innovative technologies for the analysis, characterisation and purification of biopharmaceuticals. These next-generation products are highly specific for glycan structures improving product development and improving the cost-efficiency of their manufacturing. GlycoSeLect specialises in the development of proteins based on recombinant prokaryotic lectins RPLs. Our RPL products advance efficient detection, analysis and selective isolation of glycosylated pharmaceutical products. GlycoSeLect’s family of RPLs products are associated with market-leading properties, including high affinity for glycan targets, high sensitivity of detection, high stability and robustness in process development.

More Stories